We are live on ! Find out more
KNTE

Kinnate Biopharma Inc. Common Stock

Delisted

KNTE was delisted on the 2nd of April, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
FCMI
1
Foresite Capital Management IV
California
$22.9M
O
2
OrbiMed
New York
$19M
FCMV
3
Foresite Capital Management V
California
$8.36M
TCM
4
Tang Capital Management
California
$6.17M +$4.61M +2,601,647 New
VVA
5
Vida Ventures Advisors
Massachusetts
$5.23M
LCM
6
Lynx1 Capital Management
Puerto Rico
$4.73M
Viking Global Investors
7
Viking Global Investors
Connecticut
$4.31M
Vanguard Group
8
Vanguard Group
Pennsylvania
$2.47M +$86.2K +48,698 +5%
Acadian Asset Management
9
Acadian Asset Management
Massachusetts
$1.97M +$166K +93,807 +13%
BlackRock
10
BlackRock
New York
$1.39M -$274K -154,662 -21%
Renaissance Technologies
11
Renaissance Technologies
New York
$1.36M +$122K +69,023 +14%
Millennium Management
12
Millennium Management
New York
$1.34M +$13.6K +7,674 +1%
Group One Trading
13
Group One Trading
Illinois
$1.34M +$997K +563,265 +187,755%
BCM
14
BML Capital Management
Indiana
$1.11M +$829K +468,210 New
Citadel Advisors
15
Citadel Advisors
Florida
$986K -$1.14M -644,001 -61%
GCP
16
GSA Capital Partners
United Kingdom
$803K -$62.5K -35,305 -9%
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
$725K +$284K +160,591 +110%
Two Sigma Investments
18
Two Sigma Investments
New York
$710K +$287K +162,163 +118%
AI
19
Acuitas Investments
Washington
$687K +$513K +289,766 New
Geode Capital Management
20
Geode Capital Management
Massachusetts
$547K +$16.4K +9,239 +4%
PFCS
21
Pale Fire Capital SE
Czech Republic
$523K +$266K +150,381 +214%
Marshall Wace
22
Marshall Wace
United Kingdom
$461K +$195K +110,320 +131%
Goldman Sachs
23
Goldman Sachs
New York
$370K +$137K +77,255 +98%
Two Sigma Advisers
24
Two Sigma Advisers
New York
$363K +$81.4K +46,000 +43%
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
$357K +$168K +94,885 +170%